highperformr logo

Harbour BioMed's Overview

Total employees107
HeadquartersSuzhou
Founded

Harbour BioMed (HBM) is a global, clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics in the areas of immuno-oncology and immunology. They leverage their proprietary Harbour Mice® platforms (HCAb, HBICE™) for generating fully human monoclonal antibodies. Their pipeline includes promising candidates like Batoclimab (HBM9161) and Porustobart (HBM4003), targeting a range of autoimmune diseases and cancers. HBM aims to address unmet medical needs and bring transformative therapies to patients worldwide.

Where is Harbour BioMed's Headquarters?

HQ Function

The Suzhou headquarters serves as the central hub for Harbour BioMed's global operations, including strategic leadership, core R&D activities, corporate functions, and coordination with its international sites.

Notable Features:

Located within BioBAY, the facility benefits from a vibrant ecosystem of biotech companies, research institutions, and talent. It likely features state-of-the-art laboratory spaces for antibody discovery and development.

Work Culture:

The work culture emphasizes scientific rigor, innovation, and collaboration. As a global company, it fosters an international mindset, with teams working on cutting-edge biopharmaceutical research aimed at addressing significant unmet medical needs.

HQ Significance:

Its location in Suzhou's BioBAY positions Harbour BioMed at the forefront of China's rapidly growing biotech industry, facilitating access to local talent, research collaborations, and the Chinese pharmaceutical market, while also serving as a base for global expansion.

Values Reflected in HQ: The headquarters reflects Harbour BioMed's commitment to innovation, scientific excellence, and its ambition to be a global leader in biotherapeutics, supported by its strategic placement in a high-tech biotech cluster.

Location:

Harbour BioMed maintains a significant global presence with key operational sites in China (Suzhou and Shanghai), the United States (Cambridge, MA), and Europe (Rotterdam, Netherlands). This international footprint supports its end-to-end capabilities, from antibody discovery and development through to clinical trials and potential commercialization across major pharmaceutical markets.

Street Address:

Building B7, 218 Xinghu Street, Suzhou Industrial Park

City:

Suzhou

State/Province:

Jiangsu Province

Country:

China

Harbour BioMed's Global Presence

Cambridge, MA, USA

Address: 45 Spinelli Place, Cambridge, MA 02138, USA

Serves as the North American hub for advancing clinical trials, engaging with regulatory authorities like the FDA, and fostering partnerships within the U.S. biopharmaceutical industry.

Rotterdam, Netherlands

Address: Rotterdam Science Tower, 10th floor, Marconistraat 16, 3029 AK Rotterdam, The Netherlands

Acts as the European operational and R&D center, facilitating research collaborations, clinical development in Europe, and engagement with the European Medicines Agency (EMA).

Shanghai, China

Address: Building 1, Lane 55, Chuanhe Road, Pudong New Area, Shanghai, China

Focuses on navigating the Chinese pharmaceutical market, managing clinical trials in China, and preparing for potential product launches in the region.

Buying Intent Signals for Harbour BioMed

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of Harbour BioMed

As of April 2025, Harbour BioMed' leadership includes:

Dr. Jingsong Wang - Founder, Chairman and Chief Executive Officer
Dr. Mai-Jing Liao - Chief Scientific Officer
Dr. Xiaoxiang Chen - Executive Director and Chief Business Officer
Mr. Mayank Rawat - Chief Financial Officer

Investors of Harbour BioMed

Harbour BioMed has been backed by several prominent investors over the years, including:

GIC Private Limited
Hillhouse Capital Group
Legend Capital
CDH Investments
Advantech Capital
OrbiMed Asia
Hudson Bay Capital Management
Octagon Capital Advisors

Executive New Hires/Exits in the Last 12 Months

Hire1
Exits0

In August 2023, Harbour BioMed announced the appointment of Mr. Mayank Rawat as Chief Financial Officer. No other major high-profile executive departures have been publicly announced in the last 12 months, suggesting relative stability in the senior leadership team.

New Appointments:

Mr. Mayank Rawat, Mr. Mayank Rawat joined Harbour BioMed as Chief Financial Officer.

Technology (Tech Stack) used by Harbour BioMed

Discover the tools Harbour BioMed uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Harbour BioMed Email Formats and Examples

Harbour BioMed's email format is most commonly [first_initial][last]@harbourbiomed.com or [first].[last]@harbourbiomed.com. For example, Jingsong Wang might be jwang@harbourbiomed.com.

[firstinitial][last]@harbourbiomed.com or [first].[last]@harbourbiomed.com

Format

jwang@harbourbiomed.com

Example

80%

Success rate

News and media

Harbour BioMed Official WebsiteMarch 7, 2024

Harbour BioMed Announces First Patient Dosed in Phase II Clinical Trial of Batoclimab (HL161B) for the Treatment of Thyroid Eye Disease in China

Harbour BioMed announced that the first patient has been dosed in its Phase II clinical trial of Batoclimab (HL161B) for treating Thyroid Eye Disease (TED) in China. This marks progress in evaluating Batoclimab's efficacy for TED patients....more

Harbour BioMed Official WebsiteJanuary 3, 2024

Harbour BioMed Partner CSPC Announces NMPA Approval of Porustobart (HBM4003) in Combination with Toripalimab for the Treatment of Hepatocellular Carcinoma

Harbour BioMed's partner, CSPC Pharmaceutical Group Limited, received NMPA approval in China for Porustobart (HBM4003) in combination with Toripalimab to treat advanced hepatocellular carcinoma (HCC). This is a significant milestone for HBM4003....more

Harbour BioMed Official WebsiteAugust 21, 2023

Harbour BioMed Appoints Mr. Mayank Rawat as Chief Financial Officer

Harbour BioMed announced the appointment of Mr. Mayank Rawat as its Chief Financial Officer. Mr. Rawat brings over two decades of experience in finance, particularly within the biopharmaceutical industry....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Harbour BioMed, are just a search away.